Search

Your search keyword '"Ferrari, Francesca"' showing total 20 results
Start Over Author "Ferrari, Francesca" Publisher american association for cancer research (aacr)
20 results on '"Ferrari, Francesca"'

1. Data from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

2. Supplementary Figure S1 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

3. Data from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure S3 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 2 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 1 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

7. Data from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figure S3 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure S2 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

10. Data from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 1 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 1 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure S4 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 2 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure S2 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 1 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, primary, Bellone, Stefania, primary, Schwab, Carlton L., primary, Bonazzoli, Elena, primary, Ferrari, Francesca, primary, Predolini, Federica, primary, De Haydu, Christopher, primary, Cocco, Emiliano, primary, Buza, Natalia, primary, Hui, Pei, primary, Wong, Serena, primary, Lopez, Salvatore, primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Litkouhi, Babak, primary, Schwartz, Peter E., primary, Goedings, Peter, primary, Beusker, Patrick H., primary, van der Lee, Miranda M.C., primary, Timmers, C. Marco, primary, Dokter, Wim H.A., primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure S4 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure S1 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, primary, Black, Jonathan, primary, Bellone, Stefania, primary, Bonazzoli, Elena, primary, Predolini, Federica, primary, Ferrari, Francesca, primary, Schwab, Carlton L., primary, English, Diana P., primary, Ratner, Elena, primary, Silasi, Dan-Arin, primary, Azodi, Masoud, primary, Schwartz, Peter E., primary, Terranova, Corrado, primary, Angioli, Roberto, primary, and Santin, Alessandro D., primary

Published
2023
Full Text
View/download PDF

19. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Author

Black, Jonathan, primary, Menderes, Gulden, additional, Bellone, Stefania, additional, Schwab, Carlton L., additional, Bonazzoli, Elena, additional, Ferrari, Francesca, additional, Predolini, Federica, additional, De Haydu, Christopher, additional, Cocco, Emiliano, additional, Buza, Natalia, additional, Hui, Pei, additional, Wong, Serena, additional, Lopez, Salvatore, additional, Ratner, Elena, additional, Silasi, Dan-Arin, additional, Azodi, Masoud, additional, Litkouhi, Babak, additional, Schwartz, Peter E., additional, Goedings, Peter, additional, Beusker, Patrick H., additional, van der Lee, Miranda M.C., additional, Timmers, C. Marco, additional, Dokter, Wim H.A., additional, and Santin, Alessandro D., additional

Published
2016
Full Text
View/download PDF

20. Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

Author

Lopez, Salvatore, primary, Cocco, Emiliano, additional, Black, Jonathan, additional, Bellone, Stefania, additional, Bonazzoli, Elena, additional, Predolini, Federica, additional, Ferrari, Francesca, additional, Schwab, Carlton L., additional, English, Diana P., additional, Ratner, Elena, additional, Silasi, Dan-Arin, additional, Azodi, Masoud, additional, Schwartz, Peter E., additional, Terranova, Corrado, additional, Angioli, Roberto, additional, and Santin, Alessandro D., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results